These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8977590)

  • 1. [Metastatic cancers of unknown primary site].
    Krulik M
    Presse Med; 1996 Nov; 25(35):1754-8. PubMed ID: 8977590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cancers of unknown origin: 311 cases].
    Lortholary A; Abadie-Lacourtoisie S; Guérin O; Mege M; Rauglaudre GD; Gamelin E
    Bull Cancer; 2001 Jun; 88(6):619-27. PubMed ID: 11459709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
    Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
    Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic carcinoma of unknown origin].
    Fizazi K; Culine S
    Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the management of patients with carcinoma of unknown primary.
    Deonarine P; Han S; Poon FW; de Wet C
    Scott Med J; 2013 Aug; 58(3):154-62. PubMed ID: 23960054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic cancer with unknown primary.
    Greenberg BR; Lawrence HJ
    Med Clin North Am; 1988 Sep; 72(5):1055-65. PubMed ID: 2842554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
    Greco FA; Hainsworth JD
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):77-82. PubMed ID: 7992071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer of unknown primary: clinicopathologic correlations.
    Blaszyk H; Hartmann A; Bjornsson J
    APMIS; 2003 Dec; 111(12):1089-94. PubMed ID: 14678017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of unknown primary origin: a decade of experience in a community-based hospital.
    Pimiento JM; Teso D; Malkan A; Dudrick SJ; Palesty JA
    Am J Surg; 2007 Dec; 194(6):833-7; discussion 837-8. PubMed ID: 18005780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of patients with cancer of unknown primary site.
    Hainsworth JD; Greco FA
    Oncology (Williston Park); 2000 Apr; 14(4):563-74; discussion 574-6, 578-9. PubMed ID: 10826316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
    Hainsworth JD; Greco FA
    Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
    Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
    Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unknown primary cancer].
    Furue H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer.
    Mukai H; Katsumata N; Ando M; Watanabe T
    Am J Clin Oncol; 2010 Feb; 33(1):32-5. PubMed ID: 19786850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The chemotherapy of metastases of unknown origin].
    Shparyk IaV; Bilyns'kyĭ VT
    Lik Sprava; 1996; (1-2):45-52. PubMed ID: 9005104
    [No Abstract]   [Full Text] [Related]  

  • 17. [Limit investigation in cancer of unknown primary site].
    Berglund A; Nygren P; Hagberg H; Påhlman L; Sundin A; Sundström C
    Lakartidningen; 2005 Oct 10-16; 102(41):2946-8, 2950-2. PubMed ID: 16294513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries.
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary.
    van der Gaast A; Verwij J; Planting AS; Stoter G; Henzen-Logmans SC
    J Cancer Res Clin Oncol; 1996; 122(3):181-85. PubMed ID: 8601568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.